Ocular Therapeutix (OCUL) Receivables - Other (2013 - 2017)

Ocular Therapeutix (OCUL) recorded quarterly Receivables - Other of $688000.0 in Q1 2017, up 68700.0% quarter-over-quarter from $1000.0 in Q3 2014.

Ocular Therapeutix (OCUL) Receivables - Other (2013 - 2017) Analysis & Trends

Ocular Therapeutix's Receivables - Other history runs 3 years deep, the most recent figure standing at $688000.0 for Q1 2017.

  • In Q1 2017, Receivables - Other changed N/A year-over-year to $688000.0; the TTM figure through Mar 2017 stood at $688000.0 (changed N/A YoY), while the FY2013 annual figure was $19000.0, changed N/A from the prior year.
  • Receivables - Other was $688000.0 for Q1 2017 at Ocular Therapeutix, up from $1000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $688000.0 in Q1 2017 to a low of $1000.0 in Q2 2014.
  • Historically, Receivables - Other has averaged $177250.0 across 3 years, with a median of $10000.0 in 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 9.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2017 688,000.00
Mar 31, 2017 688,000.00
Sep 30, 2014 1,000.00
Sep 30, 2014 1,000.00
Jun 30, 2014 1,000.00
Jun 30, 2014 1,000.00
Dec 31, 2013 19,000.00
Dec 31, 2013 19,000.00